Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-26 @ 12:52 AM
NCT ID: NCT00477334
Description: AEs presented in this section are the AEs greater than 1% that occured in the treatment period. SAEs presented in this section are these that were reported either during the treatment or follow-up period (one SAE was reported during the follow-up period).
Frequency Threshold: 1
Time Frame: 21 days
Study: NCT00477334
Study Brief: Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Famciclovir 1000 mg Famciclovir 1000 mg; twice a day for one day for treatment. None None 2 206 26 206 View
Placebo Comparator Placebo twice a day for one day for treatment. None None 1 98 11 98 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Heart Palpitations SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (Unspecified) View
Pancreatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Radius Fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (Unspecified) View
Pulmonary Hypertension SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (Unspecified) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Blood Pressure increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (Unspecified) View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (Unspecified) View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Adnexa uteri pain SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (Unspecified) View
Pelvic pain SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (Unspecified) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View